These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35743611)

  • 1. LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement.
    Kyriakopoulos CP; Kapelios CJ; Stauder EL; Taleb I; Hamouche R; Sideris K; Koliopoulou AG; Bonios MJ; Drakos SG
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.
    Birks EJ; Drakos SG; Patel SR; Lowes BD; Selzman CH; Starling RC; Trivedi J; Slaughter MS; Alturi P; Goldstein D; Maybaum S; Um JY; Margulies KB; Stehlik J; Cunningham C; Farrar DJ; Rame JE
    Circulation; 2020 Nov; 142(21):2016-2028. PubMed ID: 33100036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support.
    Drakos SG; Badolia R; Makaju A; Kyriakopoulos CP; Wever-Pinzon O; Tracy CM; Bakhtina A; Bia R; Parnell T; Taleb I; Ramadurai DKA; Navankasattusas S; Dranow E; Hanff TC; Tseliou E; Shankar TS; Visker J; Hamouche R; Stauder EL; Caine WT; Alharethi R; Selzman CH; Franklin S
    Circulation; 2023 Jan; 147(5):409-424. PubMed ID: 36448446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support.
    Kanwar MK; Selzman CH; Ton VK; Miera O; Cornwell WK; Antaki J; Drakos S; Shah P
    J Heart Lung Transplant; 2022 Oct; 41(10):1324-1334. PubMed ID: 35835680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
    Holzhauser L; Kim G; Sayer G; Uriel N
    Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.
    Diakos NA; Selzman CH; Sachse FB; Stehlik J; Kfoury AG; Wever-Pinzon O; Catino A; Alharethi R; Reid BB; Miller DV; Salama M; Zaitsev AV; Shibayama J; Li H; Fang JC; Li DY; Drakos SG
    J Am Coll Cardiol; 2014 Oct; 64(15):1602-12. PubMed ID: 25301465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.
    Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y
    Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
    Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
    J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support.
    Diakos NA; Taleb I; Kyriakopoulos CP; Shah KS; Javan H; Richins TJ; Yin MY; Yen CG; Dranow E; Bonios MJ; Alharethi R; Koliopoulou AG; Taleb M; Fang JC; Selzman CH; Stellos K; Drakos SG
    J Am Heart Assoc; 2021 Oct; 10(20):e020238. PubMed ID: 34595931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?
    Helman DN; Maybaum SW; Morales DL; Williams MR; Beniaminovitz A; Edwards NM; Mancini DM; Oz MC
    Ann Thorac Surg; 2000 Oct; 70(4):1255-8. PubMed ID: 11081881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.
    Barbone A; Holmes JW; Heerdt PM; The' AH; Naka Y; Joshi N; Daines M; Marks AR; Oz MC; Burkhoff D
    Circulation; 2001 Aug; 104(6):670-5. PubMed ID: 11489773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse Remodeling With Left Ventricular Assist Devices.
    Burkhoff D; Topkara VK; Sayer G; Uriel N
    Circ Res; 2021 May; 128(10):1594-1612. PubMed ID: 33983828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages.
    Shah P; Psotka M; Taleb I; Alharethi R; Shams MA; Wever-Pinzon O; Yin M; Latta F; Stehlik J; Fang JC; Diao G; Singh R; Ijaz N; Kyriakopoulos CP; Zhu W; May CW; Cooper LB; Desai SS; Selzman CH; Kfoury AG; Drakos SG
    Circ Heart Fail; 2021 May; 14(5):e007991. PubMed ID: 33947201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.
    Catino AB; Ferrin P; Wever-Pinzon J; Horne BD; Wever-Pinzon O; Kfoury AG; McCreath L; Diakos NA; McKellar S; Koliopoulou A; Bonios MJ; Al-Sarie M; Taleb I; Dranow E; Fang JC; Drakos SG
    Eur J Heart Fail; 2018 Jan; 20(1):164-174. PubMed ID: 29094485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for myocardial recovery in heart failure.
    Lenneman AJ; Birks EJ
    Curr Treat Options Cardiovasc Med; 2014 Mar; 16(3):287. PubMed ID: 24492922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
    Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
    J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.